scispace - formally typeset
Open AccessJournal ArticleDOI

Immunology of COVID-19: Current State of the Science.

Nicolas Vabret, +87 more
- 16 Jun 2020 - 
- Vol. 52, Iss: 6, pp 910-941
Reads0
Chats0
TLDR
The current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death are summarized.
About
This article is published in Immunity.The article was published on 2020-06-16 and is currently open access. It has received 1350 citations till now.

read more

Citations
More filters
Posted ContentDOI

CD127 imprints functional heterogeneity to diversify monocyte responses in human inflammatory diseases

TL;DR: This work phenotypically and molecularly characterized a human monocyte subset marked by CD127 that retained anti-inflammatory properties within the pro-inflammatory environments, uncovering remarkable functional diversity among monocytes and signifying M127 as a potential therapeutic target for human inflammatory disorders.
Posted Content

Dynamics of B-cell repertoires and emergence of cross-reactive responses in COVID-19 patients with different disease severity

TL;DR: In this paper, the authors used high-throughput sequencing of bulk and plasma B-cells collected over multiple time points during infection to characterize signatures of B-cell response to SARS-CoV-2 in 19 patients.
Journal ArticleDOI

Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID-19.

TL;DR: Data from the large randomized trials support the conclusion that CQ and HCQ do not provide any clinical improvements in disease severity and progression of SARS‐CoV‐2 patients, as well as they do not present any solid evidence of increased serious side effects.
Journal ArticleDOI

Tackling COVID19 by Exploiting Pre-existing Cross-Reacting Spike-Specific Immunity.

TL;DR: The study of pre-existing cross-reacting immunity to preand postpandemic coronaviruses provides direction for the development of targeted molecular therapy for members of this class of virus.
Journal ArticleDOI

A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients

TL;DR: Pro-inflammatory cytokines and PCT were higher in COVID-19 patients requiring ICU admission vs. non-ICU admissions despite no difference in CRP and blood/respiratory culture results between the groups.
References
More filters
Journal ArticleDOI

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

TL;DR: The epidemiological and clinical characteristics of novel coronavirus (2019-nCoV)-infected pneumonia in Wuhan, China, and hospital-associated transmission as the presumed mechanism of infection for affected health professionals and hospitalized patients are described.
Journal ArticleDOI

COVID-19: consider cytokine storm syndromes and immunosuppression

TL;DR: Re-analysis of data from a phase 3 randomised controlled trial of IL-1 blockade (anakinra) in sepsis, showed significant survival benefit in patients with hyperinflammation, without increased adverse events.
Related Papers (5)